日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

P1336:造血干细胞移植受者接受更昔洛韦和缬更昔洛韦抗病毒治疗与复发或继发性恶性肿瘤发生率增加无关

Hu, Kejia; Huang, Yue; Hu, Yongxian; Huang, He; Duarte, D; Duarte, S; Sol dos Reis, C; Silva Coelho, P; Leite, L; Branca, R; Roncon, S; Pinho Vaz, C; Campos, A